Abbott Laboratories discovers, develops, manufactures, and sells healthcare products worldwide. It operates through Established Pharmaceutical, Diagnostic, Nutritional, and Medical Devices segments, with brands like FreeStyle Libre and Ensure.
Abbott Laboratories operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for ABT.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). ABT Stock Intelligence Report. [stoxpulse.com/stocks/abt]
Disclaimer: The information on this page about Abbott Laboratories (ABT) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Abbott Laboratories.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
Earnings beat by 1%
Jun 30
MCCOY sold 27 shares
3d ago
MCCOY sold 52 shares
4d ago
How Much Upside Can BSX Stock's Growth Deliver?
12h ago
Cyberattack & Weak 2026 Outlook Weigh on BSX: Is t...
1d ago
StoxPulse AI results for ABT: Pulse Score 51/100. Primary sentiment trends from 15 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$187.45B
P/E Ratio
33.6
EPS
$1.02
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Sep 25
-1.1%
Dec 25
-0.7%
Mar 26
-0.5%
Jun 26
+1.4%
Beat estimates 1 of 4 quarters (25%)
Abbott Laboratories discovers, develops, manufactures, and sells healthcare products worldwide. It operates through Established Pharmaceutical, Diagnostic, Nutritional, and Medical Devices segments, with brands like FreeStyle Libre and Ensure.
How Much Upside Can BSX Stock's Growth Deliver?
Cyberattack & Weak 2026 Outlook Weigh on BSX: Is the Stock a Sell?
Abbott (ABT) Exceeds Market Returns: Some Facts to Consider
The Wide Divide Priced Into Boston Scientific Stock
Median Technologies Announces Formation of Strategic Review Committee and R&D Committee to Unlock Intrinsic Value and Accelerate Its eyonis® Pan-Cancer Strategy
3 Reasons to Sell PACB and 1 Stock to Buy Instead
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
Why Is Inspire (INSP) Down 4.1% Since Last Earnings Report?